3 Reasons Why You Should Bolster Your TFSA Retirement Fund’s Immune System With Shares of This Recent IPO

Jamieson Wellness Inc. (TSX:JWEL) is a play on ageing baby boomers. Here’s why the stock should be a holding in your TFSA retirement fund.

I’m usually not a fan of IPO investing, as it’s very difficult to get a firm grasp of a new publicly traded firm’s long-term trajectory given the limited amount of historical data that’s available for you to analyze. There’s a tonne of hype that follows Canadian IPOs, since good ones are few and far between, but a lot of the time, many IPOs turn out to be duds after the “honeymoon phase” ends in the weeks following new issue day.

I’ve been disapproving of many Canadian IPOs over the last year, and that’s turned out to be a winning strategy in a majority of cases thus far. Aritzia Inc. (TSX: ATZ) and Freshii Inc. (TSX: FRII) are just two names that nosedived in the weeks and months following their respective IPOs. Of course, there are exceptions, but if you’re unsure, you’re better off sitting on the sidelines as you wait for the dust to settle.

There’s absolutely no shame in doing this. It’s actually a smart way to jump in at a better price down the road since a lot of the time, IPO prices are substantially higher than they should be, because management is typically overly bullish about their growth trajectories, which are slated to accelerate as a publicly listed company.

So, in short, IPOs are ridiculously volatile and have the potential to implode shortly after you purchase shares, but there are a few rare exceptions. Jamieson Wellness Inc. (TSX: JWEL) was one of those exceptions, so I’d urged investors to pull the trigger, despite my distaste for recent IPOs.

What makes Jamieson different?

First, Jamieson is a business that’s been around for nearly a century. The company has had the chance to establish itself as one of the best brands in the vitamin, mineral, and supplements (VMS) industry. The average Canadian is probably well aware of Jamieson’s signature green-cap product and would likely opt to buy the trusted brand versus a potentially cheaper alternative whose brand name they’re uncertain of. Jamieson’s brand is powerful, and that’s allowed the company to capture ~25% of the Canadian VMS market over the course of decades. Like it or not, Jamieson has a wide moat filled with water and alligators. And the recent IPO will allow Jamieson to widen its moat at a quicker rate moving forward.

Second, the VMS market is incredibly boring! Have you noticed that Jamieson’s IPO didn’t draw a huge crowd? That’s because vitamins are nothing new, and many investors may assume there’s zero room to grow in such a primitive market. That’s likely a reason why Jamieson’s IPO didn’t rocket and plunge in the early stages. Instead, it simply rallied somewhat modestly over the months that following new issue day.

Third, Jamieson is a long-term play on the ageing baby boomer population. A large older generation means more supplement sales. Jamieson is adding new products to its portfolio and is ramping up on marketing to further promote brand awareness. Add the company’s potential China expedition into the mix, and you’ve got a stealthy growth king that may be flying under the radar of most investors.

Bottom line

IPOs are exciting, but if the company behind the IPO is boring, well, then you have a rather tame IPO that may be a great booster to your TFSA portfolio. Global VMS demand is going to surge over the next decade, and as Jamieson ramps up on its brand awareness initiatives, I think the stock is a must-buy today for those looking for next-level returns.

Stay hungry. Stay Foolish.

Fool contributor Joey Frenette has no position in any of the stocks mentioned.

More on Investing

person with spyglass looks at ocean horizon
Dividend Stocks

This 5.9% Dividend Stock Is One I’ll Never Sell — Here’s Why

This Canadian dividend stock has a great combination of a 5.8% dividend yield, resilient cash flow, and billions of dollars…

Read more »

nugget gold
Stocks for Beginners

Gold Just Had a Rough Week: Is This Canadian Miner Still Worth Buying?

Agnico Eagle shares had a rough week, but record cash flow and a net-cash balance sheet keep the thesis interesting.

Read more »

concept of growth
Dividend Stocks

The Dividend Stock I’d Never Sell, Even in a Downturn

Fortis is a dividend stock I'd hold through a downturn. Its regulated utilities and dividend growth support a patient approach…

Read more »

a person watches a downward arrow crash through the floor
Energy Stocks

This Undervalued Dividend Stock Yields 4.3% and Keeps Growing

TC Energy (TSX:TRP) is an undervalued dividend titan to buy as shares come in further.

Read more »

patient tests her eyes with a vision test at a doctor
Stocks for Beginners

Don’t Make This TFSA Contribution Room Mistake

Before adding money to your TFSA, make sure you know your actual contribution room.

Read more »

frustrated shopper at grocery store
Dividend Stocks

2 Dividend Stocks Retirees Can Count on for Decades

These two Canadian dividend stocks offer a great mix of essential businesses, regular dividends, and long-term growth investments that could…

Read more »

AI concept person in profile
Investing

2 Stocks I’d Buy Now and Hold for the Next 5 Years

These Canadian companies are positioned to benefit from long-term trends that could support their growth for years to come.

Read more »

customer comparison shops in liquor store
Dividend Stocks

How Much TFSA Income Triggers an OAS Clawback?

The OAS clawback is based on net world income, with a 2025 minimum recovery threshold of $93,454, not on a…

Read more »